4//SEC Filing
Huang Andong 4
Accession 0001209191-21-023288
CIK 0001649989other
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 6:10 PM ET
Size
5.7 KB
Accession
0001209191-21-023288
Insider Transaction Report
Form 4
Huang Andong
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-03-24+20,873→ 20,873 totalExercise: $2.27Exp: 2031-03-24→ Common Stock (20,873 underlying)
Footnotes (1)
- [F1]The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall vest in full on March 24, 2022, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan, subject to the Reporting Person providing continuous service to the Issuer through such event.
Documents
Issuer
Outlook Therapeutics, Inc.
CIK 0001649989
Entity typeother
Related Parties
1- filerCIK 0001815678
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 6:10 PM ET
- Size
- 5.7 KB